Andrew M. Baschnagel, MD close
Andrew M. Baschnagel, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Andrew M. Baschnagel, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Baschnagel is a radiation oncologist and assistant professor in the Department of Human Oncology at the University of Wisconsin School of Medicine and Public Health, Madison, WI. He specializes in treating patients with lung, esophageal and other thoracic malignancies. He also has experience in performing stereotactic body radiotherapy and intracranial stereotactic radiosurgery for the treatment of brain, spine and liver metastases. He is actively involved in UW Multidisciplinary Thoracic Program and works closely with thoracic surgeons, medical oncologists, pulmonologists and radiologists to best meet the needs of our patients. In addition to patient care, he is actively involved in translational and clinical research at the regional and national level. 



UW Carbone Cancer Center
(608) 263-8500 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital

UW School of Medicine and Public Health

Department of Human Oncology

Professional Certifications and Education

Board Certification Radiation Oncology
Residency William Beaumont Hospital, Royal Oak, MI
Internship William Beaumont Hospital, Royal Oak, MI
Medical School The State University of New York at Buffalo, Buffalo, NY

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. Baschnagel’s research focuses on translational and clinical research.  He works closely with basic scientists, physicists and clinicians with the goal of fostering new ideas and translating research findings into the clinic. He has experience in studying combinations of radiation and molecular targeted agents and biomarkers of treatment response in patients and in preclinical models. His current work focuses on improving treatment of non-small cell lung cancer, esophageal cancer  and head and neck cancer. 

PubMed Articles
Davidson SM Ko HC Harari PM Wieland AM Chen S Baschnagel AM Kimple RJ Witek ME Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer. Otolaryngol Head Neck Surg . 2018 Sep;159(3):456-465
[PubMed ID: 29611770]
Hall WA Bergom C Thompson RF Baschnagel AM Vijayakumar S Willers H Li XA Schultz CJ Wilson GD West CML Capala J Coleman CN Torres-Roca JF Weidhaas J Feng FY Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. Int J Radiat Oncol Biol Phys . 2018 Jun 1;101(2):274-284
[PubMed ID: 28964588]
Mittauer K Paliwal B Hill P Bayouth JE Geurts MW Baschnagel AM Bradley KA Harari PM Rosenberg S Brower JV Wojcieszynski AP Hullett C Bayliss RA Labby ZE Bassetti MF A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies. Cureus . 2018 Apr 4;10(4):e2422
[PubMed ID: 29872602]
Burr AR Harari PM Ko HC Chen S Yu M Baschnagel AM Kimple RJ Witek ME HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients. Otorhinolaryngol Head Neck Surg . 2018;3(1)
[PubMed ID: 30271885]
Ko HC Chen S Wieland AM Yu M Baschnagel AM Hartig GK Harari PM Witek ME Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database. Head Neck . 2017 Nov;39(11):2159-2170
[PubMed ID: 28737019]
Ko HC Harari PM Sacotte RM Chen S Wieland AM Yu M Baschnagel AM Bruce JY Kimple RJ Witek ME Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas. J Cancer Res Clin Oncol . 2017 Nov;143(11):2341-2350
[PubMed ID: 28752235]
Ko HC Harari PM Chen S Wieland AM Yu M Baschnagel AM Kimple RJ Witek ME Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx. JAMA Otolaryngol Head Neck Surg . 2017 Nov 1;143(11):1126-1133
[PubMed ID: 29049434]
Pointer KB Ko HC Brower JV Witek ME Kimple RJ Lloyd RV Harari PM Baschnagel AM Small cell carcinoma of the head and neck: An analysis of the National Cancer Database. Oral Oncol . 2017 Jun;69:92-98
[PubMed ID: 28559027]
Wojcieszynski AP Hill PM Rosenberg SA Hullett CR Labby ZE Paliwal B Geurts MW Bayliss RA Bayouth JE Harari PM Bassetti MF Baschnagel AM Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans. Technol Cancer Res Treat . 2017 Jun;16(3):366-372
[PubMed ID: 28168936]
Brower JV Baschnagel AM In Reply to Fang et al. Int J Radiat Oncol Biol Phys . 2017 Apr 1;97(5):1106-1107
[PubMed ID: 28332997]
Baschnagel AM Tonlaar N Eskandari M Kumar T Williams L Hanna A Pruetz BL Wilson GD Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas. J Oral Pathol Med . 2017 Mar;46(3):208-213
[PubMed ID: 27442811]
Johnson MD Stone B Thibodeau BJ Baschnagel AM Galoforo S Fortier LE Ketelsen B Ahmed S Kelley Z Hana A Wilson TG Robertson JM Jury RP Wilson GD The significance of Trk receptors in pancreatic cancer. Tumour Biol . 2017 Feb;39(2):1010428317692256
[PubMed ID: 28218045]
Rosenberg SA Baschnagel AM Bagley SJ Housri N Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice. Curr Oncol Rep . 2017 Jan;19(1):5
[PubMed ID: 28168606]
Brower JV Chen S Bassetti MF Yu M Harari PM Ritter MA Baschnagel AM Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012. Int J Radiat Oncol Biol Phys . 2016 Dec 1;96(5):985-993
[PubMed ID: 27869098]
Brower JV Amini A Chen S Hullett CR Kimple RJ Wojcieszynski AP Bassetti M Witek ME Yu M Harari PM Baschnagel AM Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database. Ann Oncol . 2016 Oct;27(10):1887-94
[PubMed ID: 27502703]
Johnson MD Avkshtol V Baschnagel AM Meyer K Ye H Grills IS Chen PY Maitz A Olson RE Pieper DR Krauss DJ Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys . 2016 Mar 1;94(3):537-43
[PubMed ID: 26867883]
Wilson GD Thibodeau BJ Fortier LE Pruetz BL Galoforo S Marples B Baschnagel AM Akervall J Huang J Cancer Stem Cell Signaling during Repopulation in Head and Neck Cancer. Stem Cells Int . 2016;2016:1894782
[PubMed ID: 26880935]
Baschnagel AM Galoforo S Thibodeau BJ Ahmed S Nirmal S Akervall J Wilson GD Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts. Anticancer Res . 2015 Nov;35(11):5973-82
[PubMed ID: 26504020]
Baschnagel AM Wobb JL Dilworth JT Williams L Eskandari M Wu D Pruetz BL Wilson GD The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas. Radiother Oncol . 2015 Oct;117(1):118-24
[PubMed ID: 26328941]
Wilson GD Thibodeau BJ Fortier LE Pruetz BL Galoforo S Baschnagel AM Chunta J Oliver Wong CY Yan D Marples B Huang J Glucose metabolism gene expression patterns and tumor uptake of ¹�F-fluorodeoxyglucose after radiation treatment. Int J Radiat Oncol Biol Phys . 2014 Nov 1;90(3):620-7
[PubMed ID: 25304950]